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stromal tumor started chemotherapy with sunitinib. Baseline computed tomography
showed sporadic aortic calciﬁcations and liver tumors (A). His systolic blood pressure
increased to 160 mm Hg during chemotherapy1 and decreased to 130 mm Hg with
administration of antihypertensive medication. During his sixth cycle of chemotherapy,
he developed an acute aortic dissection (AAD, Stanford A) with thrombosed false
lumen of the ascending aorta despite good control of blood pressure and reduction
of the liver tumors (B). The entry site of the AAD was already calciﬁed before chemo-
therapy as in A.
The presumable mechanism of the onset of AAD during chemotherapy with sunitinib
is interruption of vascular endothelial growth factor function, which could be related to
vascular stability.2 In this case, the AAD was considered to have developed on the basis
of simultaneous hypertension due to sunitinib and vascular fragility due to both calci-
ﬁcation and sunitinib presence. In daily practice, careful attention should be paid to the
onset of AAD in patients with sporadic aortic calciﬁcations during chemotherapy with
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